KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Cardlytics (CDLX) Equity Ratio (2017 - 2025)

Cardlytics (CDLX) has disclosed Equity Ratio for 9 consecutive years, with 0.02 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Equity Ratio fell 112.78% year-over-year to 0.02, compared with a TTM value of 0.02 through Dec 2025, down 112.78%, and an annual FY2025 reading of 0.02, down 112.78% over the prior year.
  • Equity Ratio was 0.02 for Q4 2025 at Cardlytics, down from 0.02 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.73 in Q1 2021 and bottomed at 0.02 in Q4 2025.
  • Average Equity Ratio over 5 years is 0.35, with a median of 0.35 recorded in 2023.
  • The sharpest move saw Equity Ratio skyrocketed 46.91% in 2021, then tumbled 112.78% in 2025.
  • Year by year, Equity Ratio stood at 0.55 in 2021, then crashed by 43.99% to 0.31 in 2022, then decreased by 23.31% to 0.23 in 2023, then fell by 24.09% to 0.18 in 2024, then plummeted by 112.78% to 0.02 in 2025.
  • Business Quant data shows Equity Ratio for CDLX at 0.02 in Q4 2025, 0.02 in Q3 2025, and 0.16 in Q2 2025.